TTrialPathMatch Me to Trials
← Back to trials
RecruitingHealthy VolunteersAlzheimer DiseaseAmyloid

A Study of LY4560736 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Eligible age

18–85 yrs

Accepts

All genders

Locations

4 states

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this study is to see how safe LY4560736 is and to see how much and how quickly LY4560736 gets into the bloodstream. For healthy participants, the study also looks at how much LY4560736 gets into the brain. This part of the study lasts up to 13 weeks which includes staying in the Clinical Research Unit (CRU) for at least 4 days. This group will include Japanese participants, and the Sponsor may choose to enroll Chinese participants. For participants with Alzheimer's Disease, the study will also look at levels of a specific Alzheimer's-related protein in the brain and will last up to 13 weeks which includes staying in the CRU twice, each lasts about 1 to 2 days. Japanese participants, and potentially Chinese participants, may also be enrolled in this group.

Sponsor: Eli Lilly and Company

You may qualify if…

  • ✓ Participants must meet eligibility criteria in the A1D-MC-ATMP screening protocol before entry into the treatment study.
  • ✓ To qualify as a participant of first-generation Japanese origin, the participant, the participant's biological parents, and all the participant's biological grandparents must be of exclusive Japanese descent and born in Japan.
  • ✓ To qualify as Chinese for this study, all four of the participant's biological grandparents must be of exclusive Chinese descent and born in China.

You may not qualify if…

  • ✕ Have a condition that predisposes the participant to an infection.
  • ✕ Have a current or recent acute, active infection.
  • ✕ Have active tuberculosis (TB), have or have had latent TB.
  • ✕ Are receiving therapeutic antibodies or expected to initiate treatment with therapeutic antibodies during the study.

Where it's recruiting

California

Anaheim · Irvine · Los Alamitos

Florida

Daytona Beach · Lady Lake · Maitland · Orlando …

Georgia

Decatur

Michigan

Farmington Hills

Source: ClinicalTrials.gov · NCT07843459 · last updated 2026-11-18

A Study of LY4560736 in Healthy Participants and Participants With Alz · TrialPath